Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Columbia University
Private Company Edition: More $100m-plus mega-rounds means another billion-dollar week for venture capital deals, including financings for G2 Bio, Hummingbird and Numab. Also, BioTheryX brings in $92m, Vedere launches with $77m and Eliem raises $60m two months after launching with $80m.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.
The cancer drug developer raised $55m. Also, Lyra raised $56m in the last of four biopharma IPOs in April, Biogen sold $3bn worth of debt, Oberland raised a $1.05bn fund and Praxis launched with more than $100m.
- Academic and Research Institutions
- Other Names / Subsidiaries
- Sia Lab